| | 58-22-0 Basic information More.. |
| Product Name: | Testosterone | | Synonyms: | Cristerone T;cristeronet;delta(4)-Androsten-17beta-ol-3-one;delta(sup4)-androsten-17(beta)-ol-3-one;delta(Sup4)-Androsten-17beta-ol-3-one;delta4-androsten-17beta-ol-3-one;Dofsol;Geno-cristaux Gremy | | CAS: | 58-22-0 | | MF: | C19H28O2 | | MW: | 288.43 | | EINECS: | 200-370-5 | | Mol File: | 58-22-0.mol |  |
Use
In Osteoporosis:
Testosterone replacement is not FDA approved for the prevention or treatment of osteoporosis. It should not be used solely for these indications but might be beneficial to reduce bone loss in patients needing therapy for hypogonadal symptoms. In a few studies, women receiving oral methyltestosterone 1.25 or 2.5 mg daily or testosterone implants 50 mg every 3 months had increased BMD. Various salt forms of testosterone were associated with increased BMD in some studies of hypogonadal men or senior men with normal hormone levels or mild hormonal deficiency. Transdermal gel, oral, intramuscular, and pellet testosterone products are available.
Patients using them should be evaluated within 1 to 2 months of initiation and then every 3 to 6 months thereafter.
- Testosterone
-
- US $0.00-0.00 / kg
- 2025-04-29
- CAS:58-22-0
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000
- Sustanon
-
- US $0.00-0.00 / vial
- 2025-04-29
- CAS:
- Min. Order: 1vial
- Purity: 99.99%
- Supply Ability: 3000vials
|
|
58-22-0
Recommend Suppliers |
|